CD79A and nasopharyngeal carcinoma: Although the conservation of EBNA1 of different EBV strains was not as high as that of glycoproteins (36, 37), the EBNA1 IgA ELISA kit used in this study, which measured antibody levels using the antigen fragments, was approved by the Chinese Food and Drug Administration for marketing when the mass NPC screening was initiated.